Suppression of Wnt/β-catenin signaling accelerated amyloid-β accumulation, tau phosphorylation, and synaptic dysfunction, all of which have been associated with AD pathology and cognitive decline [11,30]. This evidence concerns the gene MAPT and Alzheimer disease.